Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020168919> ?p ?o ?g. }
- W2020168919 endingPage "661" @default.
- W2020168919 startingPage "656" @default.
- W2020168919 abstract "Cisplatin (CDDP) is a widely used anticancer drug, but at high dose, it can produce undesirable side effects such as hepatotoxicity. Because silymrin has been used to treat liver disorders, the protective effect of silymarin on CDDP -induced hepatotoxicity was evaluated in rats. Hepatotoxicity was determined by changes in serum alanine aminotransferase [ALT] and aspartate aminotransferase [AST], nitric oxide [NO] levels, albumin and calcium levels, and superoxide dismutase [SOD], glutathione peroxidase [GSHPx] activities, glutathione content, malondialdehyde [MDA] and nitric oxide [NO] levels in liver tissue of rats. Male albino rats were divided into four groups, 10 rats in each. In the control group, rats were injected i.p. with 0.2 ml of propylene glycol in saline 75/25 (v/v) for 5 consecutive days [Silymarin was dissolved in 0.2 ml of propylene glycol in saline 75/25 v/v]. The second group were injected with CDDP (7.5 mg /kg, I.P.), whereas animals in the third group were i.p. injected with silymarin at a dose of 100 mg/kg/day for 5 consecutive days. The Fourth group received a daily i.p. injection of silymarin (100 mg/kg/day for 5 days) 1 hr before a single i.p. injection of CDDP (7.5 mg/kg). CDDP hepatotoxicity was manifested biochemically by an increase in serum ALT and AST, elevation of MDA and NO in liver tissues as well as a decrease in GSH and the activities of antioxidant enzymes, including SOD, GSHPx in liver tissues. In addition, marked decrease in serum NO, albumin and calcium levels were observed. Serum ALT, AST, liver NO level, MDA was found to decreased in the combination group in comparison with the CDDP group. The activities of SOD, GSHPx, GSH and serum NO were lower in CDDP group than both the control and CDDP pretreated with silymarin groups. The results obtained suggested that silymarin significantly attenuated the hepatotoxicity as an indirect target of CDDP in an animal model of CDDP-induced nephrotoxicity." @default.
- W2020168919 created "2016-06-24" @default.
- W2020168919 creator A5003295244 @default.
- W2020168919 creator A5066215869 @default.
- W2020168919 creator A5072053081 @default.
- W2020168919 date "2006-11-30" @default.
- W2020168919 modified "2023-10-11" @default.
- W2020168919 title "Silymarin Modulates Cisplatin-Induced Oxidative Stress and Hepatotoxicity in Rats" @default.
- W2020168919 cites W1549069204 @default.
- W2020168919 cites W1583963835 @default.
- W2020168919 cites W1590457525 @default.
- W2020168919 cites W1975980695 @default.
- W2020168919 cites W1977776248 @default.
- W2020168919 cites W1984545880 @default.
- W2020168919 cites W1986093151 @default.
- W2020168919 cites W1995043699 @default.
- W2020168919 cites W1999647919 @default.
- W2020168919 cites W2012484566 @default.
- W2020168919 cites W2015639909 @default.
- W2020168919 cites W2018387975 @default.
- W2020168919 cites W2037951659 @default.
- W2020168919 cites W2039018005 @default.
- W2020168919 cites W2044389511 @default.
- W2020168919 cites W2045197265 @default.
- W2020168919 cites W2045958890 @default.
- W2020168919 cites W2047474084 @default.
- W2020168919 cites W2050823333 @default.
- W2020168919 cites W2058742492 @default.
- W2020168919 cites W2060899580 @default.
- W2020168919 cites W2065565632 @default.
- W2020168919 cites W2070458525 @default.
- W2020168919 cites W2080735998 @default.
- W2020168919 cites W2088639506 @default.
- W2020168919 cites W2092145002 @default.
- W2020168919 cites W2092700255 @default.
- W2020168919 cites W2092954078 @default.
- W2020168919 cites W2094680166 @default.
- W2020168919 cites W2121394574 @default.
- W2020168919 cites W2128161758 @default.
- W2020168919 cites W4255216858 @default.
- W2020168919 doi "https://doi.org/10.5483/bmbrep.2006.39.6.656" @default.
- W2020168919 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17129399" @default.
- W2020168919 hasPublicationYear "2006" @default.
- W2020168919 type Work @default.
- W2020168919 sameAs 2020168919 @default.
- W2020168919 citedByCount "170" @default.
- W2020168919 countsByYear W20201689192012 @default.
- W2020168919 countsByYear W20201689192013 @default.
- W2020168919 countsByYear W20201689192014 @default.
- W2020168919 countsByYear W20201689192015 @default.
- W2020168919 countsByYear W20201689192016 @default.
- W2020168919 countsByYear W20201689192017 @default.
- W2020168919 countsByYear W20201689192018 @default.
- W2020168919 countsByYear W20201689192019 @default.
- W2020168919 countsByYear W20201689192020 @default.
- W2020168919 countsByYear W20201689192021 @default.
- W2020168919 countsByYear W20201689192022 @default.
- W2020168919 countsByYear W20201689192023 @default.
- W2020168919 crossrefType "journal-article" @default.
- W2020168919 hasAuthorship W2020168919A5003295244 @default.
- W2020168919 hasAuthorship W2020168919A5066215869 @default.
- W2020168919 hasAuthorship W2020168919A5072053081 @default.
- W2020168919 hasBestOaLocation W20201689191 @default.
- W2020168919 hasConcept C126322002 @default.
- W2020168919 hasConcept C134018914 @default.
- W2020168919 hasConcept C178790620 @default.
- W2020168919 hasConcept C181199279 @default.
- W2020168919 hasConcept C185592680 @default.
- W2020168919 hasConcept C2775838275 @default.
- W2020168919 hasConcept C2776151105 @default.
- W2020168919 hasConcept C2777397205 @default.
- W2020168919 hasConcept C2777622882 @default.
- W2020168919 hasConcept C2778004101 @default.
- W2020168919 hasConcept C2778401633 @default.
- W2020168919 hasConcept C2778760513 @default.
- W2020168919 hasConcept C519581460 @default.
- W2020168919 hasConcept C538909803 @default.
- W2020168919 hasConcept C55493867 @default.
- W2020168919 hasConcept C71924100 @default.
- W2020168919 hasConcept C98274493 @default.
- W2020168919 hasConceptScore W2020168919C126322002 @default.
- W2020168919 hasConceptScore W2020168919C134018914 @default.
- W2020168919 hasConceptScore W2020168919C178790620 @default.
- W2020168919 hasConceptScore W2020168919C181199279 @default.
- W2020168919 hasConceptScore W2020168919C185592680 @default.
- W2020168919 hasConceptScore W2020168919C2775838275 @default.
- W2020168919 hasConceptScore W2020168919C2776151105 @default.
- W2020168919 hasConceptScore W2020168919C2777397205 @default.
- W2020168919 hasConceptScore W2020168919C2777622882 @default.
- W2020168919 hasConceptScore W2020168919C2778004101 @default.
- W2020168919 hasConceptScore W2020168919C2778401633 @default.
- W2020168919 hasConceptScore W2020168919C2778760513 @default.
- W2020168919 hasConceptScore W2020168919C519581460 @default.
- W2020168919 hasConceptScore W2020168919C538909803 @default.
- W2020168919 hasConceptScore W2020168919C55493867 @default.
- W2020168919 hasConceptScore W2020168919C71924100 @default.
- W2020168919 hasConceptScore W2020168919C98274493 @default.
- W2020168919 hasIssue "6" @default.